RSS-Feed abonnieren
DOI: 10.1055/s-2007-990922
An Efficient and Convenient Protocol for the Synthesis of Novel 12-Aryl- or 12-Alkyl-8,9,10,12-tetrahydrobenzo[a]xanthen-11-one Derivatives [1]
Publikationsverlauf
Publikationsdatum:
03. Dezember 2007 (online)
Abstract
An efficient and direct procedure for the synthesis of novel 12-aryl- or 12-alkyl-8,9,10,12-tetrahydrobenzo[a]xanthen-11-one derivatives has been described. The process employs a three-component condensation reaction in one-pot using 2-naphthol, aldehydes and cyclic 1,3-dicarbonyl compounds in the presence of a catalytic amount of NaHSO4·SiO2 in 1,2-dichloroethane under reflux.
Key words
xanthene - three-component condensation reaction - 2-naphthol - aldehydes - cyclic 1,3-dicarbonyl compounds - NaHSO4·SiO2
Part 130 in the series ‘Studies on novel synthetic methodologies’.
-
2a
Chetia A.Saikia CJ.Lekhok KC.Boruah RC. Tetrahedron Lett. 2004, 45: 2649 -
2b
Devi I.Bhuyan PJ. Tetrahedron Lett. 2004, 45: 8625 -
2c
Wang LM.Xia J.Qin F.Qian C.Sun J. Synthesis 2003, 1241 -
2d
Trost BM. Angew. Chem., Int. Ed. Engl. 1995, 34: 259 -
3a
Prajapati D.Sandhu JS. Synlett 2004, 235 -
3b
Bose AK.Pednekar S.Ganguly SN.Chakraborty G.Manhas MS. Tetrahedron Lett. 2004, 45: 8351 -
4a
Keating TA.Armstrong RW. J. Am. Chem. Soc. 1995, 117: 7842 -
4b
Yamada T.Omote Y.Yamanaka Y.Miyazawa T.Kuwata S. Synthesis 1998, 991 -
4c
Ross GF.Herdtweck E.Ugi I. Tetrahedron 2002, 58: 6127 -
5a
Akiyama T.Matsuda K.Fuchibe K. Synlett 2005, 322 -
5b
Chowdari NS.Ramachary DB.Barbas CF. Synlett 2003, 1906 -
5c
Akiyama T.Takaya J.Kagoshima H. Tetrahedron Lett. 1999, 40: 7831 -
5d
Arend M.Westermann B.Risch N. Angew. Chem. Int. Ed. 1998, 37: 1045 - 6
Van de Water RW.Pettus TRR. Tetrahedron 2002, 58: 5367 -
7a
Wolff A.Boechmer V.Vogt W.Ugozzoli F.Andreetti GD. J. Org. Chem. 1990, 55: 5665 -
7b
No KW.Kim JE.Kwon KM. Tetrahedron Lett. 1995, 36: 8453 -
7c
Mashraqui SH.Patil MB.Mistry HD.Ghadigaonkar S.Meetsma A. Chem. Lett. 2004, 33: 1058 -
8a
Desimoni G.Tacconi G. Chem. Rev. 1975, 75: 651 -
8b
Wan P.Backer B.Diao L.Fischer M.Shi Y.Yang C. Can. J. Chem. 1996, 74: 465 -
8c
Turner AB. Q. Rev., Chem. Soc. 1964, 18: 347 -
8d
Schleigh WR. Org. Chem. Bull. 1971, 43: 1 -
9a
Gardner PD. J. Am. Chem. Soc. 1959, 51: 3364 -
9b
Angle SR.Rainer JD.Woytowiez C. J. Org. Chem. 1997, 62: 5884 -
9c
Merijan A.Gardner PD. J. Org. Chem. 1965, 30: 3965 - 10
Poupelin JP.Saint-Ruf G.Foussard-Blanpin O.Marcisse G.Uchida-Ernouf G.Lacroix R. Eur. J. Med. Chem. 1978, 13: 67 - 11
Lambert RW,Martin JA,Merrett JH,Parkes KEB, andThomas GJ. inventors; PCT Int. Appl. WO9706178. - 12
Hideo T, andTeruomi J. inventors; (Sankyo Co.) Jpn. Patent 56005480. -
13a
Saint-Ruf G.De A..Hieu HT. Bull. Chim. Ther. 1972, 7: 83 -
13b
Saint-Ruf G.Hieu HT.Poupelin JP. Naturwissenschaften 1975, 62: 584 -
14a
Ion RM. Prog. Catal. 1997, 2: 55 -
14b
Ion RM.Frackowiak D.Planner A.Wiktorowicz K. Acta Biochim. Pol. 1998, 45: 833 -
15a
Banerjee A.Mukherjee AK. Stain Technol. 1981, 56: 83 -
15b
Menchen SM,Benson SC,Lam JYL,Zhen W,Sun D,Rosenblum BB,Khan SH, andTaing M. inventors; US Patent 6583168. - 16
Knight CG.Stephens T. Biochem. J. 1989, 258: 683 -
17a
Siirkecioglu O.Talinli N.Akar A. J. Chem. Res., Synop. 1995, 502 -
17b
Ahmad M.King TA.Ko D.-K.Cha BH.Lee J. J. Phys. D: Appl. Phys. 2002, 35: 1473 -
18a
Das B.Ravikanth B.Ramu R.Laxminarayana K.Rao BV. J. Mol. Catal. A.: Chem. 2006, 255: 74 -
18b
Das B.Laxminarayana K.Ravikanth B.Rao BR. J. Mol. Catal. A: Chem. 2007, 261: 180 -
19a
Ramesh C.Ravindranath N.Das B. J. Org. Chem. 2003, 68: 7101 -
19b
Ramesh C.Mahender G.Ravindranath N.Das B. Tetrahedron Lett. 2003, 44: 1465 -
19c
Das B.Banerjee J.Ravindranath N. Tetrahedron 2004, 60: 8357 -
19d
Das B.Ravinder Reddy K.Thirupathi P. Tetrahedron Lett. 2006, 47: 5855 -
19e
Das B.Venkateswarlu K.Krishnaiah M.Holla H. Tetrahedron Lett. 2006, 47: 7551 - 20
Breton GW. J. Org. Chem. 1997, 62: 8952
References and Notes
Part 130 in the series ‘Studies on novel synthetic methodologies’.
21
General Procedure for the Synthesis of 12-Aryl- or 12-Alkyl-8,9,10,12-tetrahydrobenzo[
a
]xanthen-11-one Derivatives: NaHSO4·SiO2 (100 mg) was added to a mixture of 2-naphthol (1.0 mmol), aldehyde (1.0 mmol) and dimedone (1.2 mmol) in DCE (5 mL). The mixture was stirred at reflux conditions and the reaction was monitored by TLC. After completion of the reaction, the mixture was filtered. The filtrate was concentrated and the residue was purified by column chromatography (silica gel, 3% EtOAc in hexane) to afford the pure 12-aryl- or 12-alkyl-8,9,10,12-tetrahydrobenzo[a]xanthen-11-one derivative.
Spectral data of some representative products are given below:
Compound 3b: 1H NMR (200 MHz, CDCl3): δ = 7.86 (dd, J = 2.0, 8.0 Hz, 1 H), 7.75 (dd, J = 2.0, 8.0 Hz, 2 H), 7.11-7.46 (m, 7 H), 5.62 (s, 1 H), 2.63 (s, 2 H), 2.31 (d, J = 12.0 Hz, 1 H), 2.20 (d, J = 12.0 Hz, 1 H), 1.12 (s, 3 H), 0.91 (s, 3 H). 13C NMR (50 MHz, CDCl3): δ = 196.8, 164.0, 147.8, 143.3, 132.0, 131.5, 131.3, 129.8, 129.1, 128.5, 128.4, 127.1, 125.0, 123.5, 117.1, 117.0, 113.9, 50.9, 41.4, 34.2, 32.2, 29.3, 27.1. MS (FAB): m/z = 389, 391 [M + H]+·.
Compound 3g: 1H NMR (200 MHz, CDCl3): δ = 7.94 (dd, J = 2.0, 8.0 Hz, 1 H), 7.72 (dd, J = 2.0, 8.0 Hz, 2 H), 7.32-7.45 (m, 2 H), 7.29 (d, J = 8.0 Hz, 1 H), 7.14 (d, J = 8.0 Hz, 2 H), 6.55 (d, J = 8.0 Hz, 2 H), 5.59 (s, 1 H), 5.47 (s, 1 H), 2.58 (s, 2 H), 2.32 (d, J = 12.0 Hz, 1 H), 2.23 (d, J = 12.0 Hz, 1 H), 1.12 (s, 3 H), 1.01 (s, 3 H). 13C NMR (50 MHz, CDCl3): δ = 197.6, 164.8, 154.6, 148.1, 137.5, 131.1, 129.9, 129.9, 129.1, 128.8, 127.2, 125.0, 124.6, 117.5, 117.0, 115.2, 114.9, 50.7, 40.4, 33.2, 31.8, 29.1, 26.9. MS (FAB): m/z = 371 [M + H]+·.
Compound 3i: 1H NMR (200 MHz, CDCl3): δ = 7.92 (dd, J = 2.0, 8.0 Hz, 1 H), 7.74 (dt, J = 2.0, 8.0 Hz, 2 H), 7.42-7.55 (m, 2 H), 7.27 (d, J = 8.0 Hz, 1 H), 7.01 (d, J = 2.0 Hz, 1 H), 6.62 (d, J = 8.0 Hz, 1 H), 6.51 (dd, J = 2.0, 8.0 Hz, 1 H) 5.59 (s, 1 H), 5.28 (s, 1 H), 3.86 (s, 3 H), 2.52 (s, 2 H), 2.30 (d, J = 12.0 Hz, 1 H), 2.22 (d, J = 12.0 Hz, 1 H), 1.13 (s, 3 H), 0.99 (s, 3 H). 13C NMR (50 MHz, CDCl3): δ = 197.2, 164.6, 147.8, 146.2, 144.1, 137.4, 131.1, 128.8, 128.2, 127.0, 124.9, 124.2, 121.2, 118.0, 117.5, 114.6, 114.3, 110.9, 55.8, 50.5, 40.1, 34.2, 31.8, 29.7, 26.8. MS (FAB): m/z = 401 [M + H]+·.
Compound 3l: 1H NMR (200 MHz, CDCl3): δ = 8.07 (d, J = 8.0 Hz, 1 H), 7.77 (d, J = 8.0 Hz, 1 H), 7.64 (d, J = 8.0 Hz, 1 H), 7.49 (t, J = 8.0 Hz, 1 H), 7.38 (t, J = 8.0 Hz, 1 H), 7.12 (d, J = 8.0 Hz, 1 H), 4.69 (t, J = 7.0 Hz, 1 H), 2.50 (s, 2 H), 2.38 (d, J = 12.0 Hz, 1 H), 2.29 (d, J = 12.0 Hz, 1 H), 1.78-1.89 (m, 2 H), 1.20 (s, 3 H), 1.12 (s, 3 H), 0.61 (t, J = 7.0 Hz, 3 H). 13C NMR (50 MHz, CDCl3): δ = 197.9, 166.1, 148.8, 131.2, 131.0, 128.2, 128.1, 126.4, 124.2, 123.1, 117.8, 115.2, 111.5, 50.8, 41.1, 31.5, 29.2, 28.8, 27.3, 9.1. MS (FAB): m/z = 307 [M + H]+·.
Compound 3o: 1H NMR (200 MHz, CDCl3): δ = 7.85 (dd, J = 2.0, 8.0 Hz, 1 H), 7.80 (d, J = 8.0 Hz, 2 H), 7.06-7.48 (m, 7 H), 5.64 (s, 1 H), 2.63-2.85 (m, 2 H), 2.31-2.42 (m, 2 H), 1.92-2.11 (m, 2 H). 13C NMR (50 MHz, CDCl3): δ = 197.0, 165.8, 147.8, 143.5, 132.0, 131.5, 131.2, 130.0, 129.1, 128.5, 128.4, 127.1, 125.0, 123.5, 117.0, 116.9, 115.1, 37.0, 34.1, 27.7, 20.3. MS (FAB): m/z = 361, 362 [M + H]+·.